BBIO

BBIO Operating Cash Flow Growth

33.77%TTM

Period ending:

BBIO TTM Cash from Operations YoY %%
BBIO TTM Cash from Operations YoY %48.09%-99.91%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

BBIO operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Bridgebio Pharma Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
33.7651%
11.2844%
14.3676%
-29.8959%
-58.0721%
17.002%
1.3253%
9.2564%
14.6482%
-49.5445%
-25.7992%
-7.8232%
-8.854%
20.603%
15.7531%
0.0335%
5.0761%
-8.8403%
-24.5726%
-21.2413%
-57.877%
-67.6057%
-57.624%
-69.6423%
-40.4688%
-56.5337%
-85.5836%

Compare operating cash flow growth

All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.